MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 237 filers reported holding MIRATI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,787,659 | +27.4% | 41,039 | +5.7% | 0.10% | +32.0% |
| Q2 2023 | $1,403,072 | +19.7% | 38,834 | +23.2% | 0.08% | +4.2% |
| Q1 2023 | $1,172,174 | +347.6% | 31,527 | +445.4% | 0.07% | +323.5% |
| Q4 2022 | $261,892 | -31.3% | 5,780 | +5.9% | 0.02% | -37.0% |
| Q3 2022 | $381,000 | -0.5% | 5,457 | -4.4% | 0.03% | +12.5% |
| Q2 2022 | $383,000 | -24.8% | 5,711 | -7.7% | 0.02% | +14.3% |
| Q1 2022 | $509,000 | -49.1% | 6,190 | -9.2% | 0.02% | -36.4% |
| Q4 2021 | $1,000,000 | -24.1% | 6,816 | -8.5% | 0.03% | -25.0% |
| Q3 2021 | $1,318,000 | +488.4% | 7,450 | +469.6% | 0.04% | +388.9% |
| Q1 2021 | $224,000 | +12.0% | 1,308 | +43.4% | 0.01% | 0.0% |
| Q4 2020 | $200,000 | – | 912 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |